I thought that you would be interested to see the figures published by the Department of Health and the accompanying NCAT bulletin, which provide details of the number of successful applications made through the Cancer Drugs Fund. Currently 18,500 applications have been approved, with the majority through the permanent cancer drugs fund. I have included below a table that shows the number of treatments and money spent by each SHA through the CDF.

Whilst there is no specific mention of Dasatinib, the NCAT bulletin does reveal that it is not within the top ten drugs requested via the Cancer Drugs Fund, which make up a total of the 80% of successful applications.

Should you require any further details, the Department of Health statement can be found at the links below:

http://mediacentre.dh.gov.uk/2012/08/29/cancer-drugs-fund-usage/

http://ncat.nhs.uk/sites/default/files/uploaded/CDF%20National%20Bulletin%20Summer%202012.pdf

Strategic health authority Number of patients funded

2010-11

Amount spent 2010-11
£0002
Number of patients funded

2011-12

Amount spent

2011-12

£0002

Number of patients funded

2012-13 to end June 2012

Amount spent 2012-13

to end June 2012

£000

Total number of patients funded Oct 2010 to end June 20121
North East 420 5,249 696 6,834 119 888 1,235
North West 266 7,400 1,044 10,015 360 3,669 1,670
Yorkshire and the Humber 178 1,400 809 4,926 636 388 1,623
East Midlands 178 3,157 871 9,624 240 332 1,289
West Midlands 292 2,400 1,658 14,062 416 6,470 2,366
East of England 246 4,286 1,486 12,659 420 4,500 2,152
London 443 5,915 1,364 20,560 392 7,263 2,199
South East Coast 306 2,159 1,241 10,765 243 4,785 1,790
South Central 290 3,200 1,170 5,318 192 858 1,652
South West 161 3,088 1,459 13,565 890 5,187 2,510
Total 2,780 38,254 11,798 108,327